News

Webcast Image Webcast
Q2 2020 IRIDEX Earnings Conference Call
08/06/20 at 5:00 PM EDT

Date Title Teaser
11/02/17
Summary ToggleIRIDEX Announces 2017 Third Quarter Financial Results MOUNTAIN VIEW, Calif. , Nov. 02, 2017 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today reported financial results for the third quarter and nine months ended September 30, 2017 . Third Quarter Highlights Record third quarter revenue of $10.9 million , an 11% year-over-year increase
10/26/17
Summary ToggleIRIDEX to Present at Upcoming Investor Conferences MOUNTAIN VIEW, Calif. , Oct. 26, 2017 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company plans to participate in two upcoming investor conferences. November 9, 2017 at 1:30pm ET , IRIDEX’s management is scheduled to present at the Canaccord Genuity Medical Technologies
10/19/17
Summary ToggleIRIDEX to Report Third Quarter 2017 Financial Results on November 2, 2017 MOUNTAIN VIEW, Calif. , Oct. 19, 2017 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company will release financial results for the third quarter 2017 after the close of trading on Thursday, November 2 , 2017.  The Company’s management team will host a corresponding
08/03/17
Summary ToggleIRIDEX Announces 2017 Second Quarter, Six-Month Financial Results Updates Guidance for Full Year 2017 MOUNTAIN VIEW, Calif. , Aug. 3, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended July 1, 2017 . Second Quarter Financial Results and Highlights Total revenue of $10.0 million
07/20/17
Summary ToggleIRIDEX to Report Second Quarter 2017 Financial Results on August 3, 2017 MOUNTAIN VIEW, Calif. , July 20, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter 2017 after the close of trading on Thursday, August 3 , 2017.  The Company's management team will host a corresponding
07/18/17
Summary ToggleIRIDEX Announces Appointment Of Ann Rhoads To Its Board Of Directors MOUNTAIN VIEW, Calif. , July 18, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Ann Rhoads to the Company's Board of Directors, Audit Committee, and Compensation Committee, effective immediately. "We are delighted to add Ann to our Board of
05/24/17
Summary ToggleIRIDEX To Present At The Jefferies 2017 Global Healthcare Conference MOUNTAIN VIEW, Calif. , May 24, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Jefferies 2017 Global Healthcare Conference in New York, NY . IRIDEX's management is scheduled to present on Wednesday, June 7, 2017 at
05/04/17
Summary ToggleIRIDEX Announces Presentation Of Data Demonstrating Safety And Efficacy Of Micropulse® Technology At Upcoming Industry Conferences Results will be highlighted at upcoming ASCRS congress May 5-9 and ARVO annual meeting May 7-11 MOUNTAIN VIEW, Calif. , May 4, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today announced the presentation of data demonstrating the safety and efficacy of its proprietary MicroPulse®
05/03/17
Summary ToggleIRIDEX Announces First Quarter 2017 Financial Results Updates Guidance for Full Year 2017 MOUNTAIN VIEW, Calif. , May 3, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months ended April 1, 2017 . Recent Financial Results and Highlights Total revenue of $10.5 million for the first quarter of
04/19/17
Summary ToggleIRIDEX to Report First Quarter 2017 Financial Results on May 3, 2017 MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the first quarter 2017 after the close of trading on Wednesday, May 3 , 2017.  The Company's management team will host a corresponding
03/15/17
Summary ToggleIRIDEX To Present At The Sidoti & Co. Spring 2017 Convention MOUNTAIN VIEW, Calif. , March 15, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the Sidoti & Co. Spring 2017 Convention in New York, NY . Iridex's management is scheduled to present on Wednesday, March 29, 2017 at 3:00pm ET .
03/08/17
Summary ToggleIRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook Cyclo G6™ Glaucoma Laser Platform Fourth Quarter Revenue Up 67% Year-over-Year Record Revenue of $12.5 Million in the Fourth Quarter of 2016 MOUNTAIN VIEW, Calif. , March 8, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months and full year
02/28/17
Summary ToggleIRIDEX To Present At 29th Annual Roth Conference MOUNTAIN VIEW, Calif. , Feb. 28, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the 29 th Annual Roth Conference in Orange County, CA. Iridex's management is scheduled to present on Tuesday, March 14, 2017 at 9:30am PT .
02/28/17
Summary ToggleIRIDEX Launches New FDA-Cleared Probe At The Annual American Glaucoma Society Meeting The award winning CYCLO G6™ Glaucoma Laser System now offers a treatment with built-in transillumination MOUNTAIN VIEW, Calif. , Feb. 28, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) is pleased to announce the availability of the G-Probe™ Illuminate, a new, FDA -cleared probe offering
02/22/17
Summary ToggleIRIDEX to Report Fourth Quarter and 2016 Financial Results on March 8, 2017 MOUNTAIN VIEW, Calif. , Feb. 22, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the fourth quarter and 2016 after the close of trading on Wednesday, March 8 , 2017.  The Company's management team will host a corresponding
01/31/17
Summary ToggleBioTuesdays: Iridex MicroPulse Probes Glaucoma Continuum of Care
01/09/17
Summary ToggleIRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year MOUNTAIN VIEW, Calif. , Jan. 9, 2017 /PRNewswire/ --  IRIDEX Corporation (Nasdaq: IRIX) today reported preliminary revenues of approximately $12.4 to $12.5 million and $46.0 to $46.1 million for the fourth quarter and full year 2016, respectively, meeting the previously provided quarterly and
logo aa0 logo ags logo ascrs logo asrs logo esrs0 logo euretina